7 Results for "

Indinavir

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "Indinavir" in MCE Product Catalog:

8
8 Publications Verification
Referencia número: HY-B0689
No. CAS: 150378-17-9
Synonyms: MK-639 free base; L-735524 free base
Áreas de investigación:  

Inflammation/Immunology Cancer

Indinavir (MK-639 free base) is an orally active and selective HIV-1 protease inhibitor with a Ki of 0.54 nM for PR. Indinavir exhibits anticancer activity by inhibiting the activation of MMPs-2 hydrolysis, anti-angiogenesis and inducing apoptosis. Indinavir is also a SARS-CoV 3CL pro inhibitor .
loading...
    loading...
8
8 Publications Verification
Referencia número: HY-B0689A
No. CAS: 157810-81-6
Synonyms: MK-639; L735524
Áreas de investigación:  

Infection Cancer

Indinavir sulfate (MK-639) is an orally active and selective HIV-1 protease inhibitor with a Ki of 0.54 nM for PR. Indinavir sulfate exhibits anticancer activity by inhibiting the activation of MMPs-2 hydrolysis, anti-angiogenesis and inducing apoptosis. Indinavir sulfate is also a SARS-CoV 3CL pro inhibitor .
loading...
    loading...
Referencia número: HY-B0689C
No. CAS: 360558-79-8
Synonyms: (threo)-MK-639; (threo)-L735524
Target:  

HIV

Áreas de investigación:  

Infection

(Threo)-Indinavir is a protease inhibitor that plays an important role in HIV/AIDS suppression. (Threo)-Indinavir is used as a component of highly active antiretroviral suppression. By inhibiting the viral protease, (threo)-Indinavir ((threo)-MK-639) is able to effectively block the replication of the HIV virus .
loading...
    loading...
Referencia número: HY-B0689S
No. CAS: 185897-02-3
Synonyms: MK-639-d6 free base; L-735524-d6 free base
Indinavir-d6 is the deuterium labeled Indinavir. Indinavir (MK-639; L735524) is a potent and specific HIV protease inhibitor that appears to have good oral bioavailability.
loading...
    loading...
Referencia número: HY-B0689B
No. CAS: 2563866-80-6
Synonyms: MK-639 ethanolate; L735524 ethanolate
Áreas de investigación:  

Infection Cancer

Indinavir sulfate ethanolate (MK-639 ethanolate) is an orally active and selective HIV-1 protease inhibitor with a Ki of 0.54 nM for PR. Indinavir sulfate ethanolate exhibits anticancer activity by inhibiting the activation of MMPs-2 hydrolysis, anti-angiogenesis and inducing apoptosis. Indinavir sulfate ethanolate is also a SARS-CoV 3CL pro inhibitor .
loading...
    loading...
Referencia número: HY-B0689S1
Synonyms: MK-639 free base-13C4,15N; L-735524 free base-13C4,15N
Indinavir- 13C4, 15N (MK-639 (free base)- 13C4, 15N) is 13C and 15N labeled Indinavir. Indinavir (MK-639 free base) is an orally active and selective HIV-1 protease inhibitor with a Ki of 0.54 nM for PR. Indinavir exhibits anticancer activity by inhibiting the activation of MMPs-2 hydrolysis, anti-angiogenesis and inducing apoptosis. Indinavir is also a SARS-CoV 3CL pro inhibitor .
loading...
    loading...
Referencia número: HY-120812
No. CAS: 160729-91-9
Target:  

HIV Protease

Áreas de investigación:  

Infection

HIV-IN-11 is part of the hydroxylaminoglutaramide (HAPA) transition state isomeric series of HIV protease inhibitors and is a potent and selective inhibitor of HIV-1 protease. HIV-IN-11 competitively inhibits HIV-1 PR (Ki: 0.049 nM) and potently inhibits replication of HIV(IIIb)-infected MT4 lymphocytes at concentrations of 25.0-50.0 nM. HIV-IN-11 displays a longer half-life than indinavir sulfate in animal models and serves as a promising second-generation HIV protease inhibitor .
loading...
    loading...